$471 Million is the total value of Ghost Tree Capital, LLC's 63 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZGNX | New | ZOGENIX INCput | $22,783,000 | – | 650,000 | +100.0% | 4.84% | – |
| AVXS | New | AVEXIS INCput | $19,346,000 | – | 200,000 | +100.0% | 4.11% | – |
| DBVT | New | DBV TECHNOLOGIES S Aput | $17,125,000 | – | 403,500 | +100.0% | 3.64% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $9,460,000 | – | 50,000 | +100.0% | 2.01% | – |
| INSM | New | INSMED INCcall | $9,363,000 | – | 300,000 | +100.0% | 1.99% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $9,345,000 | – | 150,000 | +100.0% | 1.98% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $7,763,000 | – | 250,000 | +100.0% | 1.65% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $7,602,000 | – | 50,000 | +100.0% | 1.61% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $7,250,000 | – | 200,000 | +100.0% | 1.54% | – |
| RXDX | New | IGNYTA INC | $6,793,000 | – | 550,000 | +100.0% | 1.44% | – |
| PDCO | New | PATTERSON COMPANIES INC | $6,184,000 | – | 160,000 | +100.0% | 1.31% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $5,804,000 | – | 100,000 | +100.0% | 1.23% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $4,781,000 | – | 75,000 | +100.0% | 1.02% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,536,000 | – | 100,000 | +100.0% | 0.96% | – |
| MRK | New | MERCK & CO INC | $4,162,000 | – | 65,000 | +100.0% | 0.88% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $4,112,000 | – | 35,000 | +100.0% | 0.87% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $4,106,000 | – | 109,000 | +100.0% | 0.87% | – |
| INCY | New | INCYTE CORP | $4,086,000 | – | 35,000 | +100.0% | 0.87% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INCcall | $3,719,000 | – | 150,000 | +100.0% | 0.79% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $3,645,000 | – | 75,000 | +100.0% | 0.77% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $3,016,000 | – | 200,000 | +100.0% | 0.64% | – |
| KDMN | New | KADMON HLDGS INC | $2,848,000 | – | 850,000 | +100.0% | 0.60% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $2,031,000 | – | 35,000 | +100.0% | 0.43% | – |
| PTCT | New | PTC THERAPEUTICS INCcall | $2,001,000 | – | 100,000 | +100.0% | 0.42% | – |
| EXEL | New | EXELIXIS INC | $1,296,000 | – | 53,500 | +100.0% | 0.28% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,223,000 | – | 64,410 | +100.0% | 0.26% | – |
| New | NABRIVA THERAPEUTICS PLC | $983,000 | – | 120,000 | +100.0% | 0.21% | – | |
| VSAR | New | VERSARTIS INC | $674,000 | – | 275,000 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.